-
Signature
-
/s/ Hugh Rienhoff, as Attorney-in-fact for Michael Arenberg
-
Stock symbol
-
IMGO
-
Transactions as of
-
Dec 16, 2022
-
Transactions value $
-
-$586,135
-
Form type
-
4
-
Date filed
-
12/20/2022, 03:18 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
IMGO |
Common Stock |
Options Exercise |
$1.12M |
+72.6K |
|
$15.45 |
72.6K |
Dec 16, 2022 |
Direct |
|
transaction |
IMGO |
Common Stock |
Sale |
-$1.71M |
-47.8K |
-65.73% |
$35.78 |
24.9K |
Dec 16, 2022 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
IMGO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-72.6K |
-70.53% |
$0.00 |
30.4K |
Dec 16, 2022 |
Common Stock |
72.6K |
$15.45 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Operating and Business Officer On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger, by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. In connection with the Merger, to mitigate the potential impact of Section 280G and Section 4999 of the Internal Revenue Code of 1986, as amended, the Issuer accelerated the exercisability of the reported stock options and vested a portion, allowing the Reporting Person to enter into the transactions disclosed on this Form 4.